Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Gross Profit: 2019-2024

Historic Gross Profit for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $23.4 million.

  • Eton Pharmaceuticals' Gross Profit rose 24.64% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.1 million, marking a year-over-year increase of 75.62%. This contributed to the annual value of $23.4 million for FY2024, which is 11.16% up from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Gross Profit is $23.4 million, which was up 11.16% from $21.1 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Gross Profit registered a high of $23.4 million during FY2024, and its lowest value of -$247,000 during FY2020.
  • In the last 3 years, Eton Pharmaceuticals' Gross Profit had a median value of $21.1 million in 2023 and averaged $19.6 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Gross Profit plummeted by 148.81% in 2020 and then surged by 7,794.33% in 2021.
  • Over the past 5 years, Eton Pharmaceuticals' Gross Profit (MRY) stood at -$247,000 in 2020, then surged by 7,794.33% to $19.0 million in 2021, then decreased by 24.66% to $14.3 million in 2022, then soared by 47.09% to $21.1 million in 2023, then increased by 11.16% to $23.4 million in 2024.
  • Its last three reported values are $23.4 million in FY2024, $21.1 million for FY2023, and $14.3 million during FY2022.